Literature DB >> 7006674

Origin of anti-Thomsen-Friedenreich (T) and Tn agglutinins in man and in White Leghorn chicks.

G F Springer, H Tegtmeyer.   

Abstract

Interest in anti-Thomsen-Friedenreich (T) antibodies has increased because of their significance in detection of and their possible interaction with human adenocarcinoma. The origin of anti-T, which all humans possess, has not been ascertained. We determined here that anti-T and -Tn agglutinins could readily be induced via the physiological intestinal route by an enteric bacterium, E. coli O86, which possesses T and Tn activities. One dose of live E. coli O86 given in the drinking water to germfree chicks, who had no anti-T and -Tn antibodies, resulted, in all birds, in formation of saline agglutinating anti-T and -Tn antibodies as well as those detectable only by indirect agglutination. Antibody specificity was confirmed by adsorption on and elution from homologous human erythrocytes and for anti-T also by haemagglutination inhibition. In contrast, control chicks raised under ordinary conditions did have anti-T and -Tn prior to feeding E. coli O86. In humans, six diarrhoeic and five healthy infants and the majority of 13 adults investigated were fed killed rather than live E. coli O86. All infants, but one, suffering from diarrhoea showed a significant increase (greater than or equal to 4-fold) in anti-T and/or anti-Tn antibodies; in some, these antibodies were elicited de novo. All four adults with intestinal lesions had a significant increase of anti-T and/or -Tn subsequent to ingestion of E. coli O86, as did five of nine healthy adults, but to a lesser extent. These findings support the immune nature of demonstrable levels of anti-T and -Tn.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7006674     DOI: 10.1111/j.1365-2141.1981.tb02813.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  19 in total

1.  Intestinal flora, carcinomata and erythrocytes evoke anti-Tn antibodies.

Authors:  P R Desai; H Tegtmeyer; G F Springer; S Metcalfe; R J Svvennsen
Journal:  Naturwissenschaften       Date:  1987-05

2.  T and Tk antigen activation in necrotising enterocolitis: manifestations, severity of illness, and effectiveness of testing.

Authors:  D A Osborn; K Lui; P Pussell; A K Jana; A S Desai; M Cole
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

3.  Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.

Authors:  G F Springer; S M Murthy; P R Desai; W A Fry; H Tegtmeyer; E F Scanlon
Journal:  Klin Wochenschr       Date:  1982-02-01

4.  Patients mount an autoimmune response to their bladder cancer-associated t antigen.

Authors:  J M Ignatoff; G F Springer; M D Blum; H Tegtmeyer; P R Desai
Journal:  Naturwissenschaften       Date:  1983-01

Review 5.  Cancer vaccines and carbohydrate epitopes.

Authors:  Jamie Heimburg-Molinaro; Michelle Lum; Geraldine Vijay; Miten Jain; Adel Almogren; Kate Rittenhouse-Olson
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

Review 6.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 7.  IgA nephropathy enigma.

Authors:  Jiri Mestecky; Jan Novak; Zina Moldoveanu; Milan Raska
Journal:  Clin Immunol       Date:  2016-07-18       Impact factor: 3.969

Review 8.  The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.

Authors:  Lu-Gang Yu
Journal:  Glycoconj J       Date:  2007-04-25       Impact factor: 2.916

9.  Specificity of human anti-carbohydrate IgG antibodies as probed with polyacrylamide-based glycoconjugates.

Authors:  E P Smorodin; O A Kurtenkov; B L Sergeyev; G V Pazynina; N V Bovin
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

10.  Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia.

Authors:  Joel B Cochran; Valerie M Panzarino; Lanne Y Maes; Frederick W Tecklenburg
Journal:  Pediatr Nephrol       Date:  2004-01-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.